Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147


IL-33 Enhances Host Tolerance to Candida albicans Kidney Infections through Induction of IL-13 Production by CD4+ T Cells.

Tran VG, Kim HJ, Kim J, Kang SW, Moon UJ, Cho HR, Kwon B.

J Immunol. 2015 May 15;194(10):4871-9. doi: 10.4049/jimmunol.1402986. Epub 2015 Apr 6.


IL-17 plays a central role in initiating experimental Candida albicans infection in mouse corneas.

Zhang H, Li H, Li Y, Zou Y, Dong X, Song W, Jia C, Li S, Xi H, Liu D, Wang Y.

Eur J Immunol. 2013 Oct;43(10):2671-82. doi: 10.1002/eji.201242891. Epub 2013 Aug 12.


Endogenous interleukin 4 is required for development of protective CD4+ T helper type 1 cell responses to Candida albicans.

Mencacci A, Del Sero G, Cenci E, d'Ostiani CF, Bacci A, Montagnoli C, Kopf M, Romani L.

J Exp Med. 1998 Feb 2;187(3):307-17.


Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice.

Brieland J, Essig D, Jackson C, Frank D, Loebenberg D, Menzel F, Arnold B, DiDomenico B, Hare R.

Infect Immun. 2001 Aug;69(8):5046-55.


CD4(+)-T-Cell-mediated resistance to systemic murine candidiasis induced by a membrane fraction of Candida albicans.

Mizutani S, Endo M, Ino-Ue T, Kurasawa M, Uno Y, Saito H, Onogi K, Kato I, Takesako K.

Antimicrob Agents Chemother. 2000 Oct;44(10):2653-8.


IL-33 priming regulates multiple steps of the neutrophil-mediated anti-Candida albicans response by modulating TLR and dectin-1 signals.

Le HT, Tran VG, Kim W, Kim J, Cho HR, Kwon B.

J Immunol. 2012 Jul 1;189(1):287-95. doi: 10.4049/jimmunol.1103564. Epub 2012 Jun 1.


Early T cell unresponsiveness in mice with candidiasis and reversal by IL-2: effect on T helper cell development.

Spaccapelo R, Del Sero G, Mosci P, Bistoni F, Romani L.

J Immunol. 1997 Mar 1;158(5):2294-302.


CD80+Gr-1+ myeloid cells inhibit development of antifungal Th1 immunity in mice with candidiasis.

Mencacci A, Montagnoli C, Bacci A, Cenci E, Pitzurra L, Spreca A, Kopf M, Sharpe AH, Romani L.

J Immunol. 2002 Sep 15;169(6):3180-90.


T cells augment monocyte and neutrophil function in host resistance against oropharyngeal candidiasis.

Farah CS, Elahi S, Pang G, Gotjamanos T, Seymour GJ, Clancy RL, Ashman RB.

Infect Immun. 2001 Oct;69(10):6110-8.


B7/CD28-dependent CD4+CD25+ regulatory T cells are essential components of the memory-protective immunity to Candida albicans.

Montagnoli C, Bacci A, Bozza S, Gaziano R, Mosci P, Sharpe AH, Romani L.

J Immunol. 2002 Dec 1;169(11):6298-308.


Memory IL-22-producing CD4+ T cells specific for Candida albicans are present in humans.

Liu Y, Yang B, Zhou M, Li L, Zhou H, Zhang J, Chen H, Wu C.

Eur J Immunol. 2009 Jun;39(6):1472-9. doi: 10.1002/eji.200838811.


Exogenous farnesol interferes with the normal progression of cytokine expression during candidiasis in a mouse model.

Navarathna DH, Nickerson KW, Duhamel GE, Jerrels TR, Petro TM.

Infect Immun. 2007 Aug;75(8):4006-11. Epub 2007 May 21.


The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney.

Ramani K, Garg AV, Jawale CV, Conti HR, Whibley N, Jackson EK, Shiva SS, Horne W, Kolls JK, Gaffen SL, Biswas PS.

PLoS Pathog. 2016 Nov 4;12(11):e1005952. doi: 10.1371/journal.ppat.1005952. eCollection 2016 Nov.


Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells.

Netea MG, Sutmuller R, Hermann C, Van der Graaf CA, Van der Meer JW, van Krieken JH, Hartung T, Adema G, Kullberg BJ.

J Immunol. 2004 Mar 15;172(6):3712-8.


Immunogenicity and protective effect of recombinant enolase of Candida albicans in a murine model of systemic candidiasis.

Montagnoli C, Sandini S, Bacci A, Romani L, La Valle R.

Med Mycol. 2004 Aug;42(4):319-24.


Defective IL-17- and IL-22-dependent mucosal host response to Candida albicans determines susceptibility to oral candidiasis in mice expressing the HIV-1 transgene.

Goupil M, Cousineau-Côté V, Aumont F, Sénéchal S, Gaboury L, Hanna Z, Jolicoeur P, de Repentigny L.

BMC Immunol. 2014 Oct 26;15:49. doi: 10.1186/s12865-014-0049-9.


Immunization with the Candida albicans membrane fraction and in combination with fluconazole protects against systemic fungal infections.

Mizutani S, Endo M, Ino-Ue T, Kurasawa M, Uno Y, Saito H, Kato I, Takesako K.

Antimicrob Agents Chemother. 2000 Feb;44(2):243-7.


Role of CD4+ lymphocytes in resistance to mucosal candidiasis.

Cantorna MT, Balish E.

Infect Immun. 1991 Jul;59(7):2447-55.

Supplemental Content

Support Center